ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Global IntegrationSubscribe to Global Integration

India’s Domestic Pharmaceutical Firms and Their Contribution to National Innovation System-building

Domestic pharmaceutical firms continue to operate under the influence of the strategy of global integration of the pharmaceutical industry and healthcare. The link between domestic firms and public sector research organisations is the weakest link in the domestic pharmaceutical industry due to misguided policies in competence-building and innovation system-building after India accepted the Trade-Related Aspects of Intellectual Property Rights Agreement in 1995. The government should rethink its strategies to get domestic firms to contribute to system-building activities and prioritise investment into the upgrading of processes of learning and building competence.

A Maturer WTO

The biggest gain for India from the fourth ministerial conference of the World Trade Organisation that concluded at Doha on November 14 is that a fresh round of trade negotiations has been kicked off. It is also to India’s advantage that the Doha meet has incorporated into the WTO agenda several concerns of developing countries and by doing so promises to take the process of globalisation and global integration ahead. India played a proactive role in the negotiations. Although it could be argued that trade minister Maran and his team displayed more vigour in pushing what have come to be identified as India’s national postures than in correctly identifying what indeed are our national interests, there is no gainsaying that India played an important role in securing a major achievement of the summit – developing country assertion of their interests.
Back to Top